Prevention and Treatment of Opioid Misuse and Addiction: A Review
- PMID: 30516809
- DOI: 10.1001/jamapsychiatry.2018.3126
Prevention and Treatment of Opioid Misuse and Addiction: A Review
Abstract
Importance: More than 42 000 Americans died of opioid overdoses in 2016, and the fatalities continue to increase. This review analyzes the factors that triggered the opioid crisis and its further evolution, along with the interventions to manage and prevent opioid use disorder (OUD), which are fundamental for curtailing the opioid crisis.
Observations: Opioid drugs are among the most powerful analgesics but also among the most addictive. The current opioid crisis, initially triggered by overprescription of opioid analgesics, which facilitated their diversion and misuse, has now expanded to heroin and illicit synthetic opioids (fentanyl and its analogues), the potency of which further increases their addictiveness and lethality. Although there are effective medications to treat OUD (methadone hydrochloride, buprenorphine, and naltrexone hydrochloride), these medications are underused, and the risk of relapse is still high. Strategies to expand medication use and treatment retention include greater involvement of health care professionals (including psychiatrists) and approaches to address comorbidities. In particular, the high prevalence of depression and suicidality among patients with OUD, if untreated, contributes to relapse and increases the risk of overdose fatalities. Prevention interventions include screening and early detection of psychiatric disorders, which increase the risk of substance use disorders, including OUD.
Conclusions and relevance: Although overprescription of opioid medications triggered the opioid crisis, improving opioid prescription practices for pain management, although important for addressing the opioid crisis, is no longer sufficient. In parallel, strategies to expand access to medication for OUD and improve treatment retention, including a more active involvement of psychiatrists who are optimally trained to address psychiatric comorbidities, are fundamental to preventing fatalities and achieving recovery. Research into new treatments for OUD, models of care for OUD management that include health care, and interventions to prevent OUD may further help resolve the opioid crisis and prevent it from happening again.
Similar articles
-
Medications for management of opioid use disorder.Am J Health Syst Pharm. 2019 Jul 18;76(15):1097-1103. doi: 10.1093/ajhp/zxz105. Am J Health Syst Pharm. 2019. PMID: 31361869 Review.
-
Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl: A Review.JAMA Intern Med. 2024 Jun 1;184(6):691-701. doi: 10.1001/jamainternmed.2023.7282. JAMA Intern Med. 2024. PMID: 38683591 Review.
-
Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.PLoS Med. 2019 Dec 31;16(12):e1003002. doi: 10.1371/journal.pmed.1003002. eCollection 2019 Dec. PLoS Med. 2019. PMID: 31891578 Free PMC article.
-
Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks.J Stud Alcohol Drugs. 2019 Jul;80(4):393-402. J Stud Alcohol Drugs. 2019. PMID: 31495374 Review.
-
Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.Implement Sci. 2017 Nov 15;12(1):135. doi: 10.1186/s13012-017-0665-x. Implement Sci. 2017. PMID: 29141653 Free PMC article. Clinical Trial.
Cited by
-
Pre-deployment personality traits predict prescription opioid receipt over 2-year post-deployment period in a longitudinal cohort of deployed National Guard soldiers.Addict Behav. 2021 Aug;119:106919. doi: 10.1016/j.addbeh.2021.106919. Epub 2021 Mar 22. Addict Behav. 2021. PMID: 33845256 Free PMC article.
-
Lack of rewarding effects of a soluble epoxide hydrolase inhibitor TPPU in mice: Comparison with morphine.Neuropsychopharmacol Rep. 2020 Dec;40(4):412-416. doi: 10.1002/npr2.12136. Epub 2020 Sep 7. Neuropsychopharmacol Rep. 2020. PMID: 32896112 Free PMC article.
-
A genome-wide Association study of the Count of Codeine prescriptions.Sci Rep. 2024 Oct 1;14(1):22780. doi: 10.1038/s41598-024-73925-4. Sci Rep. 2024. PMID: 39354046 Free PMC article.
-
µ-Opioid Receptors Expressed by Intrinsically Photosensitive Retinal Ganglion Cells Contribute to Morphine-Induced Behavioral Sensitization.Int J Mol Sci. 2022 Dec 14;23(24):15870. doi: 10.3390/ijms232415870. Int J Mol Sci. 2022. PMID: 36555511 Free PMC article.
-
Decreased Opioid Consumption in Bone Marrow Harvest Patients Using Quadratus Lumborum Blocks in a Standardized Protocol.Front Med (Lausanne). 2022 Apr 26;9:862309. doi: 10.3389/fmed.2022.862309. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35559351 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical